OUTCOME OF PRE OPERATIVE ANAL DILATATIONS IN HIRSCHSPRUNG DISEASE IN PREVENTION OF IATROGENIC PEROPERATIVE ANAL TEARS

Status

Unknown

Phases

Phase 2Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230906003

Enrollment

Registered

2023-09-06

Start date

2021-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hirshsprung Disease Hirshsprung Disease,Heager Dilators,Anal fissures

Interventions

To see the outcome of pre operative use of hagers dilator for prevention of per operative anal tears

Experimental Device

Hagers Dilators

Eligibility

Sex/Gender

All

Age

1 Months to 16 Years

Inclusion criteria

Inclusion criteria: 1. Male/Female 2. Age 1 month to 16 years 3. Staged Procedure 4. Informed consent

Exclusion criteria

Exclusion criteria: 1.Patients who were diagnosed with comorbidities (cardiac diseases, liver diseases, 3rd degree malnutrition) 2.Lost to follow up before the final outcome can be assessed 3.History of redo surgery 4.Withdrawal of consent

Design outcomes

Primary

Measure	Time frame
To prevent iatrogenic anal tears 1 year Hagers Dilators	—

Secondary

Measure	Time frame
operative time 1 year time required from start of surgery to last stitch,hospital stay 1 year days after surgery in hospital	—

Countries

Pakistan

Contacts

Public ContactShah Syed

University of health sciences

hassan-gillani@live.com923238635535

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026